XML 74 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2015:

 

     Number of
Options
     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2014

     5,067,957       $ 33.52         

Granted

     507,916       $ 114.56         

Exercised

     (374,281    $ 23.07         

Forfeited

     (18,502    $ 78.60         
  

 

 

          

Outstanding at March 31, 2015

  5,183,090    $ 42.06      6.56    $ 451.0   
  

 

 

          

Vested and exercisable at March 31, 2015

  3,323,776    $ 22.56      5.33    $ 354.0   
  

 

 

          

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $129.07 of the Company’s common stock on March 31, 2015. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on March 31, 2015. The amounts are presented in millions.
Summary of Restricted Stock Units

The following table summarizes restricted stock unit activity for the three months ended March 31, 2015:

 

     Number of
Shares
     Weighted-
Average
Grant-Date
Fair Value
 

Unvested at December 31, 2014

     483,580       $ 76.20   

Granted

     194,171       $ 110.36   

Vested

     (74,370    $ 81.28   

Forfeited

     (7,932    $ 87.36   
  

 

 

    

Unvested at March 31, 2015

  595,449    $ 86.56   
  

 

 

    
Summary of Stock Appreciation Rights Activity

The following table summarizes stock appreciation rights activity for the three months ended March 31, 2015:

 

     Number of
Rights
     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2014

     688,228       $ 24.05         

Granted

     —           —           

Exercised

     (26,912    $ 23.20         

Forfeited

     —           —           
  

 

 

          

Outstanding at March 31, 2015

  661,316    $ 24.08      6.72    $ 69.4   
  

 

 

          

Vested and exercisable at March 31, 2015

  520,222    $ 24.11      6.71    $ 54.6   
  

 

 

          

 

(1) The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $129.07 of the Company’s common stock on March 31, 2015. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on March 31, 2015. The amounts are presented in millions.
Schedule of Black-Scholes Assumptions Used for Stock Options

The Black-Scholes assumptions used to estimate the fair value of stock options granted were as follows:

 

     Three Months Ended
March 31,
 
     2015     2014  

Risk-free interest rate

     1.56%-1.61     1.57-1.65

Estimated term (in years)

     4.98        5.23   

Estimated volatility

     50     64

Estimated dividend yield

     —         —    
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense was as follows:

 

     Three Months Ended
March 31,
 
     2015      2014  

Stock-based compensation expense recognized as:

     

R&D expenses

   $ 5,811       $ 4,122   

SG&A expenses

     7,561         5,539   
  

 

 

    

 

 

 

Total

$ 13,372    $ 9,661